Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB26FY1W8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,911
Award facts
- Contract value 100% obligated
- $19,910.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order contract by the Defense Logistics Agency (DLA) for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes with a ceiling value of $19,910.88. This is a firm fixed-price, non-set-aside delivery order issued on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA framework contract. Dupixent is a biologic immunosuppressant medication used primarily for treating eczema, asthma, and related allergic conditions. As a child contract under the broader SPE2DX IDC, this delivery order exemplifies the company's role in supporting military and federal healthcare supply chains with brand-name pharmaceutical products across multiple therapeutic domains, demonstrating its capability to meet competitive federal procurement standards.
Quick answers
Who was awarded contract SPE2DB26FY1W8?
SPE2DB26FY1W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FY1W8 worth?
The government has obligated $19,911 on SPE2DB26FY1W8.
Is contract SPE2DB26FY1W8 an order under another contract?
Yes. SPE2DB26FY1W8 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1W8 competed?
The extent of competition for SPE2DB26FY1W8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award